Global Active Pharmaceutical Ingredients (API) Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Published Date: 2021-01-22
- Report ID: 42043
- Pages: 108
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Active Pharmaceutical Ingredients (API) market in this environment.
In terms of revenue, this research report indicated that the global Active Pharmaceutical Ingredients (API) market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Active Pharmaceutical Ingredients (API) industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The SGS South Africa aims at producing XX Active Pharmaceutical Ingredients (API) in 2020, with XX % production to take place in global market, Ketlaphela Pharmaceutical accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Active Pharmaceutical Ingredients (API) Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Active Pharmaceutical Ingredients (API) Market
SGS South Africa
Ketlaphela Pharmaceutical
Yokogawa South Africa
Aurobindo pharma
Cipla
Haerbin Pharmaceutical
Lupin
Bachem
...
Major Type of Active Pharmaceutical Ingredients (API) Covered in Prudent Markets report:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Application Segments Covered in Prudent Markets Market
Synthetic APIs
Biotech APIs
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Active Pharmaceutical Ingredients (API) Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 CNS -Product Introduction and Major Manufacturers
1.1.2 Cardiovascular -Product Introduction and Major Manufacturers
1.1.3 Genitourinary/Hormonal Drugs -Product Introduction and Major Manufacturers
1.1.4 Respiratory -Product Introduction and Major Manufacturers
1.1.5 Rheumatology -Product Introduction and Major Manufacturers
1.1.6 Diabetes -Product Introduction and Major Manufacturers
1.1.7 Oncology -Product Introduction and Major Manufacturers
1.1.8 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Active Pharmaceutical Ingredients (API) Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Active Pharmaceutical Ingredients (API) Market
3.1.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Active Pharmaceutical Ingredients (API) Market
3.2.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Active Pharmaceutical Ingredients (API) Market
3.3.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Active Pharmaceutical Ingredients (API) Market
3.4.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Active Pharmaceutical Ingredients (API) Market
3.5.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Active Pharmaceutical Ingredients (API) Market
3.6.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Active Pharmaceutical Ingredients (API) Market
3.7.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Active Pharmaceutical Ingredients (API) Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2026)
5.2 Global Active Pharmaceutical Ingredients (API) Sales Value and Growth Rate (2021-2026)
6 Active Pharmaceutical Ingredients (API) Competitive Analysis
6.1 SGS South Africa
6.1.1 SGS South Africa Company Profiles
6.1.2 SGS South Africa Product Introduction
6.1.3 SGS South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Ketlaphela Pharmaceutical
6.2.1 Ketlaphela Pharmaceutical Company Profiles
6.2.2 Ketlaphela Pharmaceutical Product Introduction
6.2.3 Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Yokogawa South Africa
6.3.1 Yokogawa South Africa Company Profiles
6.3.2 Yokogawa South Africa Product Introduction
6.3.3 Yokogawa South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Aurobindo pharma
6.4.1 Aurobindo pharma Company Profiles
6.4.2 Aurobindo pharma Product Introduction
6.4.3 Aurobindo pharma Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Cipla
6.5.1 Cipla Company Profiles
6.5.2 Cipla Product Introduction
6.5.3 Cipla Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Haerbin Pharmaceutical
6.6.1 Haerbin Pharmaceutical Company Profiles
6.6.2 Haerbin Pharmaceutical Product Introduction
6.6.3 Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Lupin
6.7.1 Lupin Company Profiles
6.7.2 Lupin Product Introduction
6.7.3 Lupin Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Bachem
6.8.1 Bachem Company Profiles
6.8.2 Bachem Product Introduction
6.8.3 Bachem Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
